BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3023326)

  • 1. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.
    Cubellis MV; Nolli ML; Cassani G; Blasi F
    J Biol Chem; 1986 Dec; 261(34):15819-22. PubMed ID: 3023326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.
    Cubellis MV; Wun TC; Blasi F
    EMBO J; 1990 Apr; 9(4):1079-85. PubMed ID: 2157592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    Estreicher A; Wohlwend A; Belin D; Schleuning WD; Vassalli JD
    J Biol Chem; 1989 Jan; 264(2):1180-9. PubMed ID: 2536017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
    McNeill H; Jensen PJ
    Cell Regul; 1990 Oct; 1(11):843-52. PubMed ID: 1965151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
    Ellis V; Wun TC; Behrendt N; Rønne E; Danø K
    J Biol Chem; 1990 Jun; 265(17):9904-8. PubMed ID: 2161846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
    Behrendt N; Danø K
    FEBS Lett; 1996 Sep; 393(1):31-6. PubMed ID: 8804418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
    Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H
    J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
    Ellis V
    J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
    Conese M; Blasi F
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).
    Longstaff C; Merton RE; Fabregas P; Felez J
    Blood; 1999 Jun; 93(11):3839-46. PubMed ID: 10339491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor.
    Hashimoto K; Prystowsky JH; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1988 Jun; 90(6):823-8. PubMed ID: 2967334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine saturation of pro-urokinase receptors on human A431 cells.
    Stoppelli MP; Tacchetti C; Cubellis MV; Corti A; Hearing VJ; Cassani G; Appella E; Blasi F
    Cell; 1986 Jun; 45(5):675-84. PubMed ID: 3011276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P; Mazzieri R; Rifkin DB
    J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.
    Chapman HA; Bertozzi P; Sailor LZ; Nusrat AR
    Am J Physiol; 1990 Dec; 259(6 Pt 1):L432-8. PubMed ID: 2175557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.